HomeHQ1 • FRA
add
Oruka Therapeutics Inc
Previous close
€10.00
Day range
€10.60 - €10.60
Year range
€9.05 - €27.80
Market cap
404.23M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.33M | — |
Net income | -33.39M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -38.31M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 375.65M | — |
Total assets | 396.02M | — |
Total liabilities | 13.80M | — |
Total equity | 382.22M | — |
Shares outstanding | 37.44M | — |
Price to book | 0.08 | — |
Return on assets | -23.66% | — |
Return on capital | -24.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -33.39M | — |
Cash from operations | -24.08M | — |
Cash from investing | -359.97M | — |
Cash from financing | 40.34M | — |
Net change in cash | -343.70M | — |
Free cash flow | -38.03M | — |
About
Founded
2024
Headquarters
Website
Employees
28
